Apollo Hospitals Enterprise Ltd's Q4FY18 standalone net profit rises 23.84% yoy to Rs59.64cr : Misses Estimates

India Infoline Research Team | May 30, 2018 19:49 IST

The company’s standalone revenue stood at Rs1,862.92cr, up 14.68% yoy and 0.36% qoq.

Apollo Hospitals Enterprise Ltd Q4FY18

Standalone Results Q4FY18: (Rs. in cr)

Q4FY18 YoY (%)
Revenue 1,862.92 14.7
EBITDA 213.58 25.6
EBITDA Margin (%) 11.5 99
Net Profit (adjusted) 59.64 23.8
***EBITDA margin change is bps
View

Accumulate

Reco. Price

1032

Last updated on

10-May-2018

Apollo Hospital’s revenue in Q4FY18 grew by 14.7% yoy to Rs1,862.9cr. EBITDA increased by 25.6% yoy to Rs213.6cr from Rs170.1cr in Q4FY17. EBITDA margins in Q4FY18 were at 11.5% vs. 10.5% in Q4FY17 and 11.9% in Q3FY18. PAT grew by 23.8% yoy to Rs59.6cr in Q4FY18 vs. Rs48.2cr in Q4FY17.
  • Results are slightly below the consensus street estimates. 
  • Healthcare segment revenue grew by 10.5% yoy to Rs 1,000cr in Q4FY18.
  • Healthcare segment EBIT margins at 10.9% in Q4FY18 vs. 9.2% in Q4FY17 and 12.1% in Q3FY18.
  • Pharmacy segment revenue grew by 20% yoy to Rs863.1cr in Q4FY18.
  • Pharmacy segment EBIT margins at 3.7% in Q4FY18 vs. 3.4% in Q4FY17 and 3.8% in Q3FY18.



Technical View:

Apollo Hospitals Enterprise Ltd is currently trading at Rs. 984, down by 20.8 points or 2.07% from its previous closing of Rs. 1,004.80 on the BSE.
The scrip opened at Rs. 993.25 and has touched a high and low of Rs. 999 and Rs. 976.35 respectively. So far 2,33,937 (NSE+BSE) shares were traded on the counter. The stock is currently trading above its 200 DMA.



***Note: This is a NSE Chart

 

Advertisements

  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.